RPS7P12

Across TCGA pan-cancer cohorts, RPS7P12 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPS7P12 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS7P12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS7P12 expression acts as an unfavorable survival marker, although some lineages such as CESC and SKCM show a favorable association.

ACC, UCEC, and MESO are the cancer types where RPS7P12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.265	0.732	<.001	102	view →
UCEC	OS	Tertile	All	0.533	0.711	.001	72	view →
MESO	OS	Median	II,III,IV	0.320	0.725	.002	42	view →
CESC	OS	Tertile	All	0.739	0.539	.012	36	view →
SKCM	OS	Median	IV	0.894	0.329	.002	34	view →
READ	DFS	Tertile	II,III,IV	0.770	0.381	.004	31	view →
KIRC	DFS	Tertile	IV	0.173	0.406	.022	30	view →
KIRP	OS	Tertile	III,IV	0.111	0.697	<.001	24	view →
DLBC	DFS	Quartile	III,IV	0.070	0.833	.014	18	view →
THCA	DFS	Tertile	II,III,IV	1.000	0.548	.022	18	view →
UCS	DFS	Median	II,III,IV	0.575	0.287	.012	12	view →
GBM	DFS	Median	All	0.381	0.197	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPS7P12–ACC (OS)

Open the ACC breakdown →